DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,342,504 | +9.2% | 61,840 | +5.6% | 0.31% | +11.6% |
| Q2 2023 | $14,053,920 | +5.1% | 58,558 | +10.4% | 0.28% | -8.9% |
| Q1 2023 | $13,372,739 | +14.1% | 53,058 | +20.1% | 0.30% | +11.8% |
| Q4 2022 | $11,722,539 | +32.3% | 44,166 | +11.2% | 0.27% | +16.2% |
| Q3 2022 | $8,861,000 | -33.8% | 39,728 | -24.8% | 0.23% | -27.8% |
| Q2 2022 | $13,394,000 | +9.1% | 52,829 | +26.2% | 0.32% | +21.3% |
| Q1 2022 | $12,277,000 | +5.8% | 41,853 | +18.6% | 0.27% | +6.4% |
| Q4 2021 | $11,607,000 | +38.5% | 35,280 | +28.1% | 0.25% | +29.4% |
| Q3 2021 | $8,382,000 | +34.4% | 27,536 | +18.5% | 0.19% | +34.7% |
| Q2 2021 | $6,236,000 | +1.6% | 23,235 | -14.8% | 0.14% | -14.3% |
| Q1 2021 | $6,138,000 | +29.0% | 27,265 | +27.3% | 0.17% | +5.0% |
| Q4 2020 | $4,759,000 | +51.0% | 21,424 | +46.4% | 0.16% | +28.0% |
| Q3 2020 | $3,151,000 | +25.2% | 14,630 | +2.8% | 0.12% | +20.2% |
| Q2 2020 | $2,517,000 | +534.0% | 14,236 | +396.5% | 0.10% | +395.2% |
| Q1 2020 | $397,000 | +384.1% | 2,867 | +435.9% | 0.02% | +600.0% |
| Q4 2019 | $82,000 | +6.5% | 535 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $77,000 | +1.3% | 535 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $76,000 | +484.6% | 535 | +328.0% | 0.00% | – |
| Q4 2018 | $13,000 | -91.8% | 125 | -91.4% | 0.00% | -100.0% |
| Q3 2018 | $158,000 | -24.4% | 1,448 | -31.7% | 0.00% | -33.3% |
| Q2 2018 | $209,000 | +248.3% | 2,119 | +227.5% | 0.01% | +200.0% |
| Q4 2017 | $60,000 | +9.1% | 647 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $55,000 | 0.0% | 647 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $55,000 | 0.0% | 647 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $55,000 | -47.6% | 647 | -52.0% | 0.00% | -66.7% |
| Q4 2016 | $105,000 | +11.7% | 1,348 | +12.9% | 0.00% | 0.0% |
| Q3 2016 | $94,000 | -17.5% | 1,194 | +6.1% | 0.00% | -25.0% |
| Q2 2016 | $114,000 | -6.6% | 1,125 | -12.3% | 0.00% | 0.0% |
| Q1 2016 | $122,000 | -21.3% | 1,283 | -23.2% | 0.00% | 0.0% |
| Q4 2015 | $155,000 | +42.2% | 1,671 | +30.1% | 0.00% | +33.3% |
| Q3 2015 | $109,000 | +165.9% | 1,284 | +168.1% | 0.00% | +200.0% |
| Q2 2015 | $41,000 | – | 479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |